MYD88(L265P) Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation

In IgM monoclonal gammopathies MYD88(L265P) is a prognostic and predictive biomarker of therapy response. MYD88(L265P) detection is mainly performed by allele-specific quantitative PCR (ASqPCR), however recently, droplet digital PCR (ddPCR) has been proved to be suitable for MYD88(L265P) screening a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrante, Martina, Furlan, Daniela, Zibellini, Silvia, Borriero, Michela, Candido, Chiara, Sahnane, Nora, Uccella, Silvia, Genuardi, Elisa, Alessandria, Beatrice, Bianchi, Benedetta, Mora, Barbara, Grimaldi, Daniele, Defrancesco, Irene, Jiménez, Cristina, Cavallo, Federica, Ferrero, Dario, Dogliotti, Irene, Merli, Michele, Varettoni, Marzia, Ferrero, Simone, Drandi, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146978/
https://www.ncbi.nlm.nih.gov/pubmed/33926007
http://dx.doi.org/10.3390/diagnostics11050779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146978/
https://www.ncbi.nlm.nih.gov/pubmed/33926007
http://dx.doi.org/10.3390/diagnostics11050779

Ejemplares similares